S
17.42
-0.84 (-4.60%)
| Previous Close | 18.26 |
| Open | 18.00 |
| Volume | 1,592,400 |
| Avg. Volume (3M) | 454,460 |
| Market Cap | 742,344,576 |
| Price / Sales | 4.47 |
| Price / Book | 4.81 |
| 52 Weeks Range | |
| Earnings Date | 4 Aug 2025 - 8 Aug 2025 |
| Profit Margin | -15.03% |
| Operating Margin (TTM) | -15.82% |
| Diluted EPS (TTM) | -0.630 |
| Quarterly Revenue Growth (YOY) | 24.90% |
| Total Debt/Equity (MRQ) | 22.21% |
| Current Ratio (MRQ) | 8.52 |
| Operating Cash Flow (TTM) | -9.77 M |
| Levered Free Cash Flow (TTM) | -12.02 M |
| Return on Assets (TTM) | -8.51% |
| Return on Equity (TTM) | -15.96% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | SI-BONE, Inc. | Bearish | Bearish |
AIStockmoo Score
0.0
| Analyst Consensus | 4.0 |
| Insider Activity | 3.0 |
| Price Volatility | -1.5 |
| Technical Moving Averages | -5.0 |
| Technical Oscillators | -0.5 |
| Average | 0.00 |
|
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 3.13% |
| % Held by Institutions | 96.30% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Champlain Investment Partners, Llc | 31 Mar 2025 | 2,595,731 |
| First Light Asset Management, Llc | 31 Mar 2025 | 1,612,408 |
| Paradigm Capital Management Inc/Ny | 31 Mar 2025 | 1,275,455 |
| Bellevue Group Ag | 31 Mar 2025 | 872,991 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 25.00 (Cantor Fitzgerald, 43.51%) | Buy |
| Median | 24.00 (37.77%) | |
| Low | 22.00 (Truist Securities, 26.29%) | Buy |
| Average | 23.67 (35.88%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 16.45 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Cantor Fitzgerald | 06 May 2025 | 25.00 (43.51%) | Buy | 16.45 |
| Needham | 06 May 2025 | 24.00 (37.77%) | Buy | 16.45 |
| Truist Securities | 06 May 2025 | 22.00 (26.29%) | Buy | 16.45 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| DAVIS TIMOTHY E JR | 19.06 | - | 8,675 | 165,346 |
| DUNN JEFFREY W | 19.06 | 19.06 | 5,298 | 100,980 |
| FREUND JOHN GORDON | 19.06 | - | 8,675 | 165,346 |
| HILLEMAN JERYL L | 19.06 | - | 8,675 | 165,346 |
| HINCKLEY GREGORY K | 19.06 | - | 8,675 | 165,346 |
| NISHIMURA MIKA | 19.06 | - | 8,675 | 165,346 |
| WEST THOMAS A. | 19.06 | - | 8,675 | 165,346 |
| WOLF DANIEL W | 19.06 | - | 8,675 | 165,346 |
| Aggregate Net Quantity | 66,023 | |||
| Aggregate Net Value ($) | 1,258,398 | |||
| Aggregate Avg. Buy ($) | 19.06 | |||
| Aggregate Avg. Sell ($) | 19.06 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| WOLF DANIEL W | Director | 05 Jun 2025 | Acquired (+) | 8,675 | 19.06 | 165,346 |
| DAVIS TIMOTHY E JR | Director | 05 Jun 2025 | Acquired (+) | 8,675 | 19.06 | 165,346 |
| FREUND JOHN GORDON | Director | 05 Jun 2025 | Acquired (+) | 8,675 | 19.06 | 165,346 |
| HINCKLEY GREGORY K | Director | 05 Jun 2025 | Acquired (+) | 8,675 | 19.06 | 165,346 |
| HILLEMAN JERYL L | Director | 05 Jun 2025 | Acquired (+) | 8,675 | 19.06 | 165,346 |
| NISHIMURA MIKA | Director | 05 Jun 2025 | Acquired (+) | 8,675 | 19.06 | 165,346 |
| WEST THOMAS A. | Director | 05 Jun 2025 | Acquired (+) | 8,675 | 19.06 | 165,346 |
| DUNN JEFFREY W | Director | 05 Jun 2025 | Acquired (+) | 8,675 | 19.06 | 165,346 |
| DUNN JEFFREY W | Director | 05 Jun 2025 | Sell (-) | 3,377 | 19.06 | 64,366 |
| Date | Type | Details |
|---|---|---|
| 04 Jun 2025 | Announcement | SI-BONE to Truist Securities MedTech Conference on June 17, 2025 |
| 28 May 2025 | Announcement | SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025 |
| 06 May 2025 | Announcement | SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025 |
| 05 May 2025 | Announcement | SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance |
| 14 Apr 2025 | Announcement | SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |